NCT07074067

Brief Summary

The v-NOTES surgical approach may provide important advantages over the already established effective technique (laparoscopy) for safely and successfully removing the uterus and adnexa in patients with low-grade endometrioid adenocarcinoma FIGO IA and atypical endometrial hyperplasia, such as a better aesthetic outcome, a shorter hospital stays, and a decrease in pain and postoperative complications. without increasing surgical time and with equal safety for the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 11, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 27, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 20, 2025

Completed
Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

2.9 years

First QC Date

June 27, 2025

Last Update Submit

July 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time taken to perform surgery

    Surgical time will be defined, in the case of the laparoscopic/robotic route, as the time elapsed from the insertion of the first trocar to the removal of the last one, and in the case of the v-NOTES route, as the time elapsed from the beginning of the vaginal surgery to the end of the surgery. The previous time of positioning of the patient, anesthesia, asepsis and sizing of the surgical field will not be taken into account

    Perioperative

Secondary Outcomes (6)

  • AGE

    Day 1

  • Body Mass Index

    Day 1

  • times spent in surgical techniques

    1 day post surgery

  • Measurement of post-surgical pain

    6 and 24 hours after the intervention

  • Study of overall patient satisfaction upon hospital discharge

    Trough study completion, an average of a1 year

  • +1 more secondary outcomes

Study Arms (2)

Laparoscopic surgery

ACTIVE COMPARATOR

within the laparoscopic (LPC) arm, 21 patients will be assigned to conventional LPC and another 21 to robotic surgery, consecutively.

Procedure: Laparoscopic surgery

surgery via v-NOTES

EXPERIMENTAL

surgery via v-NOTES

Procedure: surgery via v-NOTES

Interventions

the laparoscopic (LPC) arm, 21 patients will be assigned to conventional LPC and another 21 to robotic surgery, consecutively.

Laparoscopic surgery

surgery via v-NOTES

surgery via v-NOTES

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with endometrial cancer
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of majority (\> 18 years)
  • Willingness to participate in the study and signing of informed consent
  • Histological diagnosis, by endometrial biopsy (either using a Cornier cannula or directed by diagnostic hysteroscopy) of atypical endometrial hyperplasia or low-grade endometrioid adenocarcinoma (G1-G2), with an initial stage (IA) at preoperative evaluation

You may not qualify if:

  • Pregnant Women
  • Nullicottitis
  • Severe uterine prolapse (grade IV)
  • Large myomatous uterus (greater than 18 weeks of gestation)
  • Severe comorbidities that contraindicate surgery, such as sepsis, severe renal failure, severe cardiopulmonary disease, or severe coagulopathies 33
  • Presence of previous illnesses or treatments that may have caused severe pelvic adhesions that obliterate the Douglas pouch and prevent vaginal entry, such as deep pelvic endometriosis, severe pelvic inflammatory disease, inflammatory bowel disease (ulcerative colitis, diverticulitis, Crohn's disease), or a history of pelvic radiotherapy, among others
  • Concomitant presence of adnexal masses or formations of considerable size that are expected to substantially lengthen the uterus Surgical time due to the difficulty of extraction
  • Contraindication to general anesthesia
  • Active pelvic or lower urinary tract infection
  • Clinical suspicion of advanced stage of the neoplasia
  • Any histological type of endometrial cancer other than those described previously.
  • High histological grade (G3)
  • Current abnormality in cervical cytology (CVC) requiring more aggressive surgical intervention
  • Revocation of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HCUVA

Murcia, Murcia, 30120, Spain

Location

MeSH Terms

Interventions

Laparoscopy

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Rafael Guijarro Campillo, MD

    HCUVA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective, open-label, longitudinal, randomized, longitudinal, blind-blind third-party (observer-blind)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2025

First Posted

July 20, 2025

Study Start

July 11, 2022

Primary Completion

May 27, 2025

Study Completion

May 27, 2025

Last Updated

July 20, 2025

Record last verified: 2025-07

Locations